Skip to main content
. 2019 Nov 17;24(1):772–784. doi: 10.1111/jcmm.14786

Figure 6.

Figure 6

A schematic model indicating that SPRY4‐IT1 competitively binds to miR‐217 and TCF7L2, consequently regulating the Wnt/β‐catenin signalling pathway to promote stemness of breast cancer cells